While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, ...

BioVersys and partners publish in the prestigious journal of Nature Communications pre-clinical development data of AlpE (alpibectir and ethionamide), an innovative drug combination that overcomes ...

A phase 3 trial of two tuberculosis vaccines shows limited overall protection but meaningful efficacy against extrapulmonary ...

Enhanced Bacteriological Response: The study reveals that high-dose rifampicin increased the 8-week sputum conversion rate ...

Two new vaccines to prevent tuberculosis (TB) are safe for use in adults and children, but they do not offer protection ...

Personalized cancer vaccines are showing real clinical results, with melanoma patients on the mRNA-4157/pembrolizumab ...

The two new tuberculosis vaccines could be safe for use in adults and children in India but may not provide protection against all forms of the infectious bacterial disease, according to phase-3 trial ...

A phase-3 trial published in The British Medical Journal finds two new TB vaccines, VPM1002 and Immuvac, safe for use in India but not effective against all forms of tuberculosis, though they may help ...

A new study warns that eye tuberculosis can cause inflammation even after successful treatment. Ocular TB, including TB-SLC, ...

New TB vaccines show safety but limited protection against all infection forms, particularly for adolescents and adults, phase-3 study reveals.

Tuberculosis shows how gaps in India’s urban health systems, combined with socio-economic disenfranchisement and migration, ...